Weight‑loss jabs may create a new kind of yo‑yo dieting

Дата публикации: 10-07-2026 13:20:07

For many people living with obesity, newer weight-loss medicines such as Wegovy and Mounjaro have been transformative. These drugs are often grouped under the label GLP-1 medicines because they mimic hormones released after eating, helping people feel fuller and less hungry. Mounjaro, whose active ingredient is tirzepatide, also acts on another hormone involved in appetite and blood sugar control.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Most obesity drugs do not improve quality of life or heart health, analysis indicates	-2	7	08-07-2026
2	Wegovy pills 'are just as good as fat jabs when it comes to weight loss - but injections are better for your heart'	0	5	09-07-2026
3	New GLP-1 diabetes pill delivers major weight loss and blood sugar control	0	6.91	15-06-2026
4	Weight-loss jab users more likely to report changes in taste and smell, study finds	0	7	29-06-2026
5	This new diabetes pill burns fat without the downsides of Ozempic	0	7.39	03-06-2026
6	New weight loss pill beats oral Ozempic in major trial	0	9.35	07-07-2026
7	Eli Lilly's Mounjaro shows heart health benefits in head-to-head trial with older diabetes drug Trulicity	7	8	31-07-2025
8	I lost 4st on Mounjaro, but my once thick and glossy hair was wrecked. I tried expensive shampoos and treatments but nothing worked. Then I started taking this supplement, with a wonder ingredient, and it's transformed my looks	2	6	24-06-2026
9	GLP-1 use hits record high as Medicare opens access to weight-loss drugs	0	7	09-07-2026
10	Ozempic and Wegovy can protect against neurological disease that causes brain damage	0	9.82	15-12-2025

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 7. Источник: medicalxpress.com.